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Abstract: Introduction: The use of vagal nerve stimulation is identified as a proper treatment option in patients with
stable supraventricular tachycardia (SVT). This study aimed to assess the success of Valsalva maneuver via a
handmade device in reversion of SVT. Methods: In this quasi experimental study, using a handmade device,
vagus nerve stimulation was performed for SVT patients presenting to emergency department or cardiac inter-
vention unit and the success rate and its related factors were assessed. Results: 100 patients with the mean age
of 53.05 ± 13.70 years were studied (67% female). 12 (12%) cases were unable to do the maneuver. Out of the 88
(88.0%) patients who could perform the maneuver, 75 (85.2%) cases were unsuccessful. Dysrhythmia was con-
trolled in 6 (6.8%) cases on the first attempt and in 7 (8.0%) cases on the second one (14.8% total success rate).
12 of the 13 cases (92.3%) of successful maneuver had history of SVT (p = 0.031). There was not any significant
association between success rate and sex (p = 0.084), age (p = 0.744), or other medical histories (p ≥ 0.05).
Conclusion: Based on the results of the present study, the success rate of Valsalva maneuver with the mentioned handmade
device was calculated to be 14.8%. The only independent related factor of successful reversion was SVT history.
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1. Introduction
S
upraventricular tachycardia (SVT) comprises a com-
mon group of cardiac arrhythmia in patients referring
to emergency departments. The overall incidence of
this acute phenomenon has been estimated to be 35 cases
per 100,000 patients (1). SVT symptoms are often non-
specific, which include chest pain, shortness of breath, sense
of palpitation, pounding in the neck, and even some degree
of psychological disturbances such as anxiety (2). Impulse
formation and impulse conduction processes may both be
disturbed (3).
In fact, three mechanisms of triggered activity, reentry, or
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increased automaticity with atrioventricular node source or
above cardiac tissue source may be involved in SVT (4).
Hence, the initial management of SVT involves slow atrioven-
tricular node conduction by evolving pharmacological ap-
proaches, mechanical maneuvers, or invasive approaches if
required (5-14).
The use of vagal maneuvers is now identified as a proper
treatment option for patients with stable SVT but its success
rate varies between 6% and 54% (15-19). There are different
options for performing vagal maneuvers including the Val-
salva maneuver and carotid sinus massage (20). However,
there is no measurable and controlled method in this regard.
The present study aimed to assess the success of Valsalva ma-
neuver via a handmade device in reversion of SVT.
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2. Methods
2.1. Study design and setting
This quasi experimental multicenter study was performed
from Oct 2014 to Oct 2016 at four general educational hos-
pitals (Imam Hossein, Shohadaye Tajrish, Loghman Hakim,
and Modarres Hospitals), Tehran, Iran. Using a handmade
device, vagus stimulation was performed for patients pre-
senting to emergency department or cardiac intervention
unit following SVT. The study protocol was approved by
ethics committee of Shahid Beheshti University of Medical
Sciences. All researchers adhered to principles of Helsinki
declaration and confidentiality of patients’ information.
2.2. Participants
The study was conducted on patients >18 years old who con-
secutively presented to emergency departments of the men-
tioned hospitals with the initial evidence of SVT (n = 45) or
were scheduled for inducing arrhythmia by a cardiologist at
cardiac intervention unit (n = 55). Patients who were not
able to perform the maneuver or did not give consent, those
with hemodynamic instability, atrial fibrillation or flutter,
malignant hypertension, or other contraindications for per-
forming Valsalva maneuver (such as cerebral AVM, increased
intraocular pressure, glaucoma, or third trimester of preg-
nancy) were excluded.
2.3. Procedure
For creating the Valsalva maneuver’s handmade device, the
cuff of the sphygmomanometer was disconnected and the
device’s pressure monitor was connected to a 90cm oxygen
connector, and the end of connector was connected to a 10cc
syringe (figure 1). Maneuver was performed at supine posi-
tion and with 30 to 50 mmHg pressure for 15 seconds. If the
first attempt was unsuccessful, another attempt was made
after five minutes. In cases of unsuccessful reversion with
two Valsalva maneuver, pharmacological approach was be-
gun. During the maneuver performance, all required sup-
portive instruments including intubation and defibrillation
sets were available and the patients were under continuous
cardiac and blood pressure monitoring.
2.4. Outcome
Achieving sinus rhythm following the first or second maneu-
ver attempt was considered as the main outcome of study
(successful maneuver).
2.5. Statistical Analysis
Results were presented as mean ± standard deviation (SD)
or frequencies and percentages. Chi-square or Fisher’s exact
tests and t test were used for comparisons. Data were ana-
lyzed using SPSS 21 statistical software. P values of 0.05 or
Figure 1: The handmade device used in the present study.






20 – 40 16 (16)
40 – 60 50 (50)
≥ 60 34 (34)
Medical history
Hypertension 17 (17)
Diabetes mellitus 19 (19)
Smoking 10 (10)
Ischemic heart disease 17 (17)
SVT 67 (67)
Arrhythmias 6 (6)
Calcium blocker use 11 (11)
Beta blocker use 45 (45)
Weight (kg) 73.8 ± 13.8
Height (cm) 165.0 ± 8.2
Heart rate (beats/minute) 173.3 ± 25.7
Data were presented as mean ± standard deviation or num-
ber (%). SVT: Supraventricular tachycardia.
less were considered statistically significant.
3. Results
3.1. Baseline characteristics
100 patients with the mean age of 53.05 ± 13.70 years (22 - 85)
were studied (67% female). The baseline characteristics of
the subjects are summarized in Table 1. Most patients were
in the age range of 40 – 60 years and 67% of them had his-
tory of SVT. SVT had resulted from atrio-ventricular nodal re-
entrant tachycardia (AVNRT) in 59%, atrio-ventricular reen-
trant tachycardia (AVRT) in 14%, and unknown origin in 27%.
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3.2. Maneuver Outcome
12 (12%) cases were unable to do the maneuver. Out of
the 88 (88.0%) patients who could perform the maneuver,
75 (85.2%) cases were unsuccessful. Dysrhythmia was con-
trolled in 6 (6.8%) cases at the first attempt and in 7 (8.0%)
cases at the second one (14.8% total success rate). 12 of the
13 cases (92.3%) of successful maneuver had history of SVT
(p = 0.031). There was not any significant association be-
tween success rate and sex (p = 0.084), age (p = 0.744), or
other medical histories (p ≥ 0.05). Unable and unsuccessful
cases were treated with ablation (52.9%), adenosine (40.4%),
amiodarone (4.5%), and verapamil (2.2%).
4. Discussion
Based on the results of the present study, the success rate
of Valsalva maneuver with the introduced handmade device
was estimated to be 14.8%. The only independent related fac-
tor of successful reversion was SVT history. Along with med-
ications and ablation, the use of vagal maneuvers has been
introduced as an alternative modality leading to reversion of
AVRT and AVNRT in up to 54% of affected patients (17, 21).
Vagal maneuver can be the most successful method to re-
verse arrhythmias if the maneuver is performed in supine
position with adequate intra-thoracic pressure (at least 30
mmHg) for at least 15 seconds (22, 23). Despite considering
all the mentioned conditions, the success rate of this maneu-
ver has been considerably low in almost all studies. As shown
in our study, the vagal maneuver was successful only in 14.8%
of subjects. This rate was about 19.4% in the report by Lim
et al. (17). However, in animal and laboratory-based studies
as well as in the new modified version of Valsalva maneuver,
the rate of reversion was shown to be in the range of 45.9%
to 54.3% (1, 21). Taylor et al. showed that only few num-
ber of physicians give enough instructions to their patients
regarding the position, duration, pressure and other charac-
teristics of maneuver (24). According to the second finding
of our study, with respect to main determinants of the suc-
cess of Valsalva maneuver to reverse SVT, none of the base-
line characteristics, except for previous experiment of SVT,
could predict high success rate for this maneuver. Higher
success of this maneuver to terminate SVT in those with pre-
vious SVT might be due to more careful and cautious perfor-
mance of the maneuver by the specialists in this high risk
group or more excitability of cardiac conductive system of
those cases by inducing maneuver. It seems that, a major-
ity of patients who suffer from SVT may not benefit from Val-
salva maneuver and thus, employing the modified maneuver
is more recommended. Higher success of this maneuver in
patients with history of SVT requires more evaluation. There-
fore, further studies with larger and heterogonous samples
and proper follow up are recommended.
5. Limitation
In this study, more than half of the participants were patients
with induced arrhythmia by cardiologist, which may affect
the response to treatment.
6. Conclusion
Based on the results of the present study, the success rate
of Valsalva maneuver with the mentioned handmade device
was calculated to be 14.8%. The only independent related
factor of successful reversion was SVT history.
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